Tuesday, February 21, 2017

Tag: VRX

Most Recent analysts Ratings: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

What are Analysts opinions on: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Comprehensive Stock Analysis of: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

what are Analysts report about: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Earnings Analysis of: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

what are Analysts report about: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Stock’s Earning Overview: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX)reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference between...

Comprehensive Stock Analysis of: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

What do Analysts Say about: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Most Recent analysts Ratings: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Worth Watching Stock: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Investors Catching Stocks: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...